65,437 trials
Hepatitis B, Chronic
Primary: Complete Virologic Response (CVR, Serum HBV DNA Undetectable by PCR or Less Than 60 IU/mL) — 13; 2 participants
Asthma
Primary: Exhaled Nitric Oxide at Baseline and Over the Observational Period — 15.1; 9.9; 13.7; 8.6 parts per billion
Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma
Primary: To Establish the Overall Response Rate Measured at 24 Weeks After First Dose of Lenalidomide Using This Dosing Regimen — 0; 5; 28 participants
Retinal Vein Occlusion
Primary: Incidence of Serious Adverse Events. — 17 number of serious adverse events
Cervical Neoplasia
Primary: Sensitivity and Specificity — 0.86; 0.80 % of participants correctly diagnosed
Hematologic Diseases · Acute Myelogenous Leukemia · Myelodysplastic Syndrome
Primary: Participant Responses — 20; 21; 9; 12 participants
Pain
Primary: Ischemic Pain — 4.31; 3.49; 3.44 units on a scale — p=<0.001
Rheumatoid Arthritis
Primary: Change From Baseline in Rheumatoid Arthritis Erosion Score Measured From MRI Assessments (RA-MRI ES) at Month 6 — 0.00; 0.00; 0.49 units on a scale — p=0.264
Graft Rejection · Kidney Transplantation · Renal Transplantation
Primary: Number of Participants With an Episode of Clinically-suspected and Biopsy-proven Acute Rejection (CSPAR) — 5; 4; 6 Participants
Healthy Males · Male Contraceptive
Primary: Maximum Testosterone Concentration — 471; 444; 543 ng*hr/dL
Bipolar Depression
Primary: We Measured the Change in Rate Constant of Creatine Kinase in Individuals With Bipolar Depression Treated With CoQ 10 as Compared With Age and Gender Matched Controls…
Stroke
Primary: Fugl-Meyer Assessment for Motor Recovery (FM) Scale — 3.01; 3.19; -2.08; 3.87 units on a scale — p=0.08
Healthy
Primary: Skin Reaction Score — 0.4; 0.5; 0.1; 0.4 units on a scale
Amphetamine Dependence
Primary: Number Negative Urines (Proportion Negative Urines) — 560; 634 Urine Drug Screen
Arthroplasty Replacement Knee · Knee Prosthesis
Primary: Patella Flexion With Respect to Femur — 80.0; 83.4; 93.7 degrees